← Open Payments lookup

M SAFWAT WAHBA: Open Payments

NPI 1821097692 · BRIDGETON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,200 in 133 payments from 15 companies in 2025. Trend: 2023 $1,443 · 2024 $1,545 · 2025 $2,200

Food & beverage: $2,093Education: $107
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.31$492
Otsuka America Pharmaceutical, Inc.27$465
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$450
Alkermes, Inc.13$184
E.R. Squibb & Sons, L.L.C.10$167
Neurocrine BioSciences, Inc.10$155
Lundbeck LLC5$91
ABBVIE INC.3$54
Axsome Therapeutics, Inc.2$31
Supernus Pharmaceuticals, Inc.1$22

Products named: REXULTI, FANAPT, CAPLYTA, ARISTADA, COBENFY, INGREZZA, VRAYLAR, Auvelity.

Industry payments across MO — which companies pay providers there.